UnitedHealth Group is experiencing profitability challenges due to high utilization and significant losses in Medicare Advantage members, leading to a forecasted 2% revenue decline in 2025. However, a 2.48% Medicare Advantage rate increase by CMS in 2027 is expected to generate about $3.94 billion in additional revenue. This boost could help UnitedHealth improve benefits, bid more aggressively, expand its market, and resume buybacks as its financial position strengthens. The analyst remains bullish on UnitedHealth, expecting earnings growth to accelerate post-2027 as the company refocuses on profitable areas and benefits from regulatory changes.
UnitedHealth Group reported a strong second-quarter net income of $5.48 billion, driven by a significant reduction in medical costs. The company lowered its medical care ratio to 86.7% from 89.4% year-over-year by exiting unprofitable markets and man...
UnitedHealth Group reported second-quarter earnings that surpassed expectations, driven by better management of high medical costs and AI investments to streamline operations. The company raised its 2026 adjusted earnings forecast to $19.50-$20 per s...
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
